With the autoimmune wave breathing financial life back into the allogeneic space, and a growing number of oncology pipelines entering the clinic, the allogeneic community are eagerly anticipating what lies ahead!

Making now the ideal time to attend the 7th Annual Allogeneic Cell Therapies Summit (June 10-12 | Boston, MA), your flagship forum uniting the top allogeneic developers including Atara Bio, Adicet Bio, Senti Bio, Glycostem and more.

What Will 2025 Offer?

• Ground-breaking Clinical Readouts: Dive into the latest results from CAR-T therapies with Atara Bio and Adicet Bio.
• Solid Tumor Breakthroughs: Hear from Senti Bio, NKILT Therapeutics, and Synaptimmune on how allogeneic therapies are targeting the tumor microenvironment to unlock entirely new indications.
• Manufacturing at Scale: Learn how Tevogen and Cell BioEngines are navigating the complexities of scalable, high-quality manufacturing to make these therapies commercially viable.
• Beyond Oncology: Broaden your scope by discovering how Biosyngen and Adicet Bio are leveraging allogeneic platforms to address autoimmune disorders.

As regulatory frameworks evolve to accommodate these revolutionary therapies and investment creeps back into allogeneic development, staying informed is no longer optional. Get involved today to be part of the conversations solving today’s challenges and shaping tomorrow’s breakthroughs.

Find out more: https://ter.li/o21go2